These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 14780830)

  • 1. [Experimental basis of the use of d-l-methionine in the treatment of liver disease].
    HARTMANN F
    Pharmazie; 1950 Aug; 5(8):367-75. PubMed ID: 14780830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acceleration of intestinal absorption of d-l-methionine in the course of hepatic steatoses. Control of the phenomen on by the study of S 35-d-l-methionine absorption].
    WARTER J; METAIS P; WERYHA A; SACREZ A
    Rev Med Suisse Romande; 1960 Apr; 80():260-75. PubMed ID: 13842971
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of d-1-methionine in the metabolism of the diseased liver; the excretion of paired sulfuric acids in liver disease and the effect of methionine].
    HARTMANN F
    Dtsch Arch Klin Med; 1949; 196(5):439-44. PubMed ID: 15405961
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the intestinal absorption of d-l-methionine in the course of hepatic steatosis].
    WARTER J; METAIS P; SACREZ A; SCHIRARDIN H
    Rev Fr Etud Clin Biol; 1959 Nov; 4():895-900. PubMed ID: 13842969
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in methionine and sulfur metabolism in the presence of liver damage; rate of utilization and urinary excretion of the D and L isomers following intravenous administration.
    KINSELL LW; HARPER HA; BARTON HC
    J Clin Invest; 1948 Jul; 27(4):543. PubMed ID: 18935170
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigations on the effect of methionine on the course of evipal narcosis in experimental liver disease].
    GREWE HE; KREMER K
    Zentralbl Chir; 1951; 76(8):516-21. PubMed ID: 14837347
    [No Abstract]   [Full Text] [Related]  

  • 7. [The hepatoses, their clinical picture and histological basis].
    ROBBERS H; RUMELIN K
    Dtsch Arch Klin Med; 1952; 199(5-6):502-13. PubMed ID: 13033519
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of oral methionine loads in normal subjects and patients with liver diseases using an analyzer short program].
    Peters WH; Lubs H; Knoke M; Zschiesche M
    Acta Biol Med Ger; 1977; 36(10):1435-43. PubMed ID: 616159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of methionine on the resistance in experimental anoxia and on related liver diseases].
    VENTURI VM
    Riv Med Aeronaut; 1951; 14(4):650-4. PubMed ID: 14949975
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and experimental study of the hepatic action of a disodium salt of methionine (succinyl-methionine)].
    LANGERON L; CORDONNIER V; GIARD P; MICHAUX P
    Rev Med Chir Mal Foie; 1951 Oct; 26(10):5-24; contd. PubMed ID: 14912754
    [No Abstract]   [Full Text] [Related]  

  • 11. Methionine metabolism and liver disease.
    Mato JM; Martínez-Chantar ML; Lu SC
    Annu Rev Nutr; 2008; 28():273-93. PubMed ID: 18331185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and experimental study of the hepatic action of a disodium salt of methionine (succinyl-methionine)].
    LANGERON L; CORDONNIER V; GIARD P; MICHAUX P
    Rev Med Chir Mal Foie; 1951 Nov; 26(11):5-22; concl. PubMed ID: 14912755
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional exploration of the liver with S35-labelled methionine in acute and chronic liver diseases].
    HOLAN T; SZANTAI I; FARCASANU M
    Rev Int Hepatol; 1963; 13():59-66. PubMed ID: 13961257
    [No Abstract]   [Full Text] [Related]  

  • 14. [STUDIES ON METHIONINE METABOLISM. 3. ON LIVER FUNCTION TESTS WITH METHIONINE LOAD].
    CHIYOTANI K
    Tohoku Igaku Zasshi; 1963 Jul; 68():102-5. PubMed ID: 14198166
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms and consequences of the impaired trans-sulphuration pathway in liver disease: Part I. Biochemical implications.
    Mato JM; Corrales F; Martin-Duce A; Ortiz P; Pajares MA; Cabrero C
    Drugs; 1990; 40 Suppl 3():58-64. PubMed ID: 2081481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of methionine on certain metabolic liver disorders].
    KNAPP K
    Med Monatsschr; 1951 Aug; 5(8):568-73. PubMed ID: 14862920
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of choline and methionine, testosterone propionate, and dietary protein on nitrogen balance in patients with liver disease.
    GABUZDA GJ; ECKHARDT RD; DAVIDSON CS
    J Clin Invest; 1950 May; 29(5):566-76. PubMed ID: 15415461
    [No Abstract]   [Full Text] [Related]  

  • 18. STATUS of methionine in the prevention and treatment of liver injury.
    J Am Med Assoc; 1947 Jan; 133(2):107. PubMed ID: 20278622
    [No Abstract]   [Full Text] [Related]  

  • 19. Basal and post-methionine serum homocysteine and lipoprotein abnormalities in patients with chronic liver disease.
    Ben-Ari Z; Tur-Kaspa R; Schafer Z; Baruch Y; Sulkes J; Atzmon O; Greenberg A; Levi N; Fainaru M
    J Investig Med; 2001 Jul; 49(4):325-9. PubMed ID: 11478408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipotropic substances in the treatment of liver disease].
    CZECH W
    Med Klin; 1950 Jun; 45(24):753-7. PubMed ID: 15438559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.